|
Market Closed -
Nasdaq
16:00:00 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 0.9800 USD | -2.00% |
|
-0.51% | -85.55% |
Company Valuation: Cadrenal Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 9.636 | 25.83 | 15.85 | 3.496 | - | - |
| Change | - | 168.05% | -38.62% | -77.95% | - | - |
| Enterprise Value (EV) | 9.636 | 25.83 | 15.85 | 3.496 | 3.496 | 3.496 |
| Change | - | 168.05% | -38.62% | -77.95% | 0% | 0% |
| P/E | -1.19x | -1.66x | -1.02x | -0.25x | -0.33x | -0.53x |
| PBR | - | - | - | - | - | - |
| PEG | 0x | 0.27x | 0x | 0x | 0x | 0x |
| Capitalization / Revenue | - | - | - | - | - | - |
| EV / Revenue | - | - | - | - | - | - |
| EV / EBITDA | -0x | -0x | - | -0.28x | -0.18x | -0.15x |
| EV / EBIT | -0x | -0x | -0x | -0.27x | -0.2x | -0.18x |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -9.3 | -8.73 | -6.64 | -3.863 | -3.007 | -1.85 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - |
| EBITDA 1 | -7.631 | -10.96 | - | -12.6 | -19.2 | -22.8 |
| EBIT 1 | -7.633 | -10.96 | -13.46 | -12.75 | -17.35 | -19.4 |
| Net income 1 | -8.357 | -10.65 | -13.24 | -12.6 | -17.2 | -16.45 |
| Net Debt | - | - | - | - | - | - |
| Reference price 2 | 11.0985 | 14.4900 | 6.7800 | 0.9800 | 0.9800 | 0.9800 |
| Nbr of stocks (in thousands) | 868 | 1,782 | 2,338 | 3,568 | - | - |
| Announcement Date | 3/11/24 | 3/13/25 | 3/31/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.25x | - | - | - | 3.5M | |
| 17.43x | 6.68x | 12.81x | 1.71% | 66.7B | |
| 30.07x | 8.27x | 26.77x | 0.07% | 56.88B | |
| 38.45x | 6.84x | 20.45x | 0.85% | 56.53B | |
| 48.64x | 6.27x | 34.36x | -.--% | 46.49B | |
| 35.48x | 3.35x | 14.48x | -.--% | 44.8B | |
| -22.45x | 63.4x | -21.48x | -.--% | 41.59B | |
| 35.87x | 8.84x | 23.03x | 0.37% | 35.35B | |
| 42.3x | 8.09x | 26.47x | -.--% | 33.29B | |
| -69.1x | 13.21x | -71.01x | -.--% | 25.1B | |
| Average | 15.64x | 13.88x | 7.32x | 0.33% | 40.67B | |
| Weighted average by Cap. | 21.89x | 13.02x | 11.80x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CVKD Stock
- Valuation Cadrenal Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
